Ares Capital (NASDAQ:ARCC – Get Rating) was upgraded by StockNews.com from a “sell” rating to a “hold” rating in a report released on Wednesday.
A number of other equities analysts have also recently weighed in on ARCC. Raymond James cut their price target on Ares Capital from $21.00 to $20.50 and set an “outperform” rating for the company in a report on Wednesday, October 26th. JPMorgan Chase & Co. reduced their target price on shares of Ares Capital from $21.00 to $20.50 and set an “overweight” rating on the stock in a report on Wednesday. Wells Fargo & Company decreased their price target on shares of Ares Capital from $20.00 to $19.00 and set an “overweight” rating on the stock in a research note on Monday, October 24th. Finally, Citigroup boosted their price objective on shares of Ares Capital from $21.00 to $22.00 and gave the company a “buy” rating in a research report on Wednesday. One analyst has rated the stock with a hold rating and seven have issued a buy rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $20.57.
Ares Capital Price Performance
NASDAQ ARCC traded down $0.09 during mid-day trading on Wednesday, hitting $19.95. The stock had a trading volume of 2,215,866 shares, compared to its average volume of 2,946,560. The company has a 50 day simple moving average of $19.00 and a 200 day simple moving average of $19.09. The company has a market cap of $10.14 billion, a price-to-earnings ratio of 11.80 and a beta of 1.01. Ares Capital has a 52-week low of $16.53 and a 52-week high of $23.00. The company has a quick ratio of 0.81, a current ratio of 0.81 and a debt-to-equity ratio of 1.26.
Hedge Funds Weigh In On Ares Capital
About Ares Capital
Ares Commercial Finance provides asset-based cash flow solutions to small and middle-market companies. ACF works with borrowers to deliver creative, flexible, and comprehensive financing solutions. Ares Commercial Finance has the ability to structure and agent deals to support the growth and changing capital needs of clients.
- Get a free copy of the StockNews.com research report on Ares Capital (ARCC)
- CVS Health Corporation Is Coiled And Ready To Spring Higher
- Will The Pullback In Paycom Payoff For Investors?
- TJX Among Apparel Retailers All Dressed Up & Ready For Growth
- Daqo New Energy Charged Up For New Highs
- No Spice In Chipotle Results, Is Now The Time To Buy?
Receive News & Ratings for Ares Capital Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ares Capital and related companies with MarketBeat.com's FREE daily email newsletter.